Observational studyAmerican journal of hematology2021
Serologic response to mRNA COVID-19 vaccination in lymphoma patients.
Abstract readLetterObservational Study
In one paragraph
Observational study in American journal of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 7 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 7 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis.Blood cancer journal · 2022Pooled it
- A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies.International immunopharmacology · 2022Pooled it
- COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis.Clinical lymphoma, myeloma & leukemia · 2022Pooled it
- Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis.Haematologica · 2022Pooled it
- Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis.Blood advances · 2022Pooled it
- Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.The oncologist · 2022Pooled it
- Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022Pooled it
- SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment.Vaccines · 2024Article
- Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis.JMA journal · 2024Review
- Article
- Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma.Frontiers in oncology · 2024Article
- Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma.Annals of hematology · 2023Article
- Review
- Immune Response to COVID-19 Vaccination in Hematologic Malignancies: A Mini-Review.Chonnam medical journal · 2023Review
- A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer response.Analytical biochemistry · 2022Review
- Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.Transplantation and cellular therapy · 2022Article
- Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients.Bone marrow transplantation · 2022Article
- COVID-19 vaccination in cancer patients: a narrative review.The Journal of international medical research · 2022Review
- Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center.Journal of clinical medicine · 2022Article
- Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer.Cancer discovery · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Eric Matthew JurgensDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.ORCID 0000-0001-8280-2581
Thomas Joseph KetasDepartment of Microbiology and Immunology, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Zhen ZhaoDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Michael Joseph SatlinDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Catherine Butkus SmallDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Ashley SukhuDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Erik FrancomanoDepartment of Microbiology and Immunology, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Per Johan KlasseDepartment of Microbiology and Immunology, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Arcania GarciaDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Emeline NguyenduyDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Erica BhavsarDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Silvia FormentiDepartment of Radiation Oncology, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Richard FurmanDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
John Philip MooreDepartment of Microbiology and Immunology, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
John Paul LeonardDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Peter MartinDepartment of Medicine, Weill Cornell Medicine-New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.
Funding
Structural studies of native-like SOSIP trimersP01AI110657 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI MOORE, JOHN P · 2015 to 2024
$35.4MNeutralization of Primate Immunodeficiency VirusesR01AI036082 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI JOHN P MOORE · 1994 to 2026
$4.3MNational Institute of Allergy and Infectious Diseases R01 AI36082NIAID NIH HHS P01 AI110657NIAID NIH HHS R01 AI036082Weill Cornell Medical College
Abstract
PubMed holds no abstract for this paper.
Indexed as
Case-Control StudiesCOVID-19 VaccinesHumansImmunoglobulin GLymphomaCOVID-19 VaccinesImmunoglobulin G
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.